Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2021

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	September 30, 2021		December 31, 2020
Prepaid research and development	$	5,500	$	2,462
Prepaid bonus		800		409
Prepaid clinical trial		779		944
Prepaid insurance		144		2,480
Other		1,162		331
Total prepaid expenses and other current assets	$	8,385	$	6,626

Schedule of Property Plant and Equipment

	September 30, 2021			December 31, 2020
Leasehold improvements	$	1,876		$	—
Furniture and fixtures		759			—
Computer equipment		818			95
Laboratory equipment		476			—
Construction in progress		36,916			201
		40,845			296
Accumulated depreciation		(292	)		(9	)
Property, plant and equipment, net	$	40,553		$	287

Schedule of Accrued Expense and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	September 30, 2021		December 31, 2020
Accrued research and development	$	9,330	$	2,106
Accrued compensation		5,752		1,766
Accrued professional and consulting fees		1,386		999
Accrued property, plant, and equipment		2,774		173
Accrued clinical trial		1,142		—
Other		779		91
Total accrued expenses and other current liabilities	$	21,163	$	5,135